SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001851734-22-000517
Filing Date
2022-08-31
Accepted
2022-08-31 16:52:48
Documents
12
Period of Report
2022-10-14

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A vtgn20220823_def14a.htm DEF 14A 822216
2 card01.jpg GRAPHIC 167268
3 card02.jpg GRAPHIC 144832
4 curley.jpg GRAPHIC 5343
5 new_vtgn.jpg GRAPHIC 7723
6 vtgn20220818_pre14aimg002.jpg GRAPHIC 5379
7 vtgn20220818_pre14aimg005.jpg GRAPHIC 6148
8 vtgn20220818_pre14aimg006.jpg GRAPHIC 7337
9 vtgn20220818_pre14aimg008.jpg GRAPHIC 5995
10 vtgn20220818_pre14aimg009.jpg GRAPHIC 5259
11 vtgn20220818_pre14aimg010.jpg GRAPHIC 5694
12 vtgn20220818_pre14aimg011.jpg GRAPHIC 5379
  Complete submission text file 0001851734-22-000517.txt   1326074
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-37761 | Film No.: 221218520
SIC: 2834 Pharmaceutical Preparations